Clinical Roundup ACS study shows medical financial hardship increases mortality risk for cancer survivors May 06, 2022Vol.48 No.18
Clinical Roundup ACS study: AYA cancer survivors face increased cancer incidence and mortality risk May 06, 2022Vol.48 No.18
Clinical Roundup SWOG study: Patients with metastatic prostate cancer living significantly longer May 06, 2022Vol.48 No.18
Clinical Roundup ASCO guidelines describe best practices for treating CAR T-cell toxicities May 06, 2022Vol.48 No.18
Clinical Roundup GIST researchers develop deep learning model to predict adverse drug-drug interactions May 06, 2022Vol.48 No.18
Clinical Roundup Racial and ethnic disparities persist for early-stage breast cancer detection and survival May 06, 2022Vol.48 No.18
Clinical Roundup Combination therapy targeting angiogenesis drivers demonstrates durable clinical activity in platinum-resistant ovarian cancer May 06, 2022Vol.48 No.18
Drugs & Targets Imfinzi + chemo granted FDA Priority Review for locally advanced or metastatic biliary tract cancer May 06, 2022Vol.48 No.18
Drugs & Targets Aptose granted Fast Track Designation from FDA for HM43239 in relapsed/refractory AML patients and FLT3 Mutation May 06, 2022Vol.48 No.18
